Sepsis severe or septic shock: Outcome according to immune status and immunodeficiency profile

Chest

Volumn 146, Issue 5, 2014, Pages 1205-1213

  Tolsma, Violaine ^a   Schwebel, Carole ^a   Azoulay, Elie ^b   Darmon, Michael ^c   Souweine, Bertrand ^d   Vesin, Aurélien ^a   Goldgran Toledano, Dany ^e   Lugosi, Maxime ^a   Jamali, Samir ^f   Cheval, Christine ^g   Adrie, Christophe ^h   Kallel, Hatem ⁱ   Descorps Declere, Adrien ^j   Garrouste Orgeas, Maïté ^k,m   Bouadma, Lila ^l,m   Timsit, Jean Franc¸ois ^a,l,m  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e Gonesse Hospital   (France)

^f Dourdan Hospital   (France)

^g Hyeres Hospital   (France)

^h DELAFONTAINE HOSPITAL   (France)

ⁱ CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^j HÔPITAL ANTOINE BÉCLÈRE   (France)

^k SAINT JOSEPH HOSPITAL   (France)

^l BICHAT HOSPITAL   (France)

^m UNIVERSITÉ PARIS DIDEROT   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL INFECTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; IMMUNE STATUS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INTENSIVE CARE UNIT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; OBSERVATIONAL STUDY; PROGNOSIS; SEPSIS; SEPTIC SHOCK; SOLID TUMOR; CLINICAL TRIAL; EPIDEMIOLOGY; FOLLOW UP; FRANCE; IMMUNITY; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TRENDS;

AGED; FEMALE; FOLLOW-UP STUDIES; FRANCE; HOSPITAL MORTALITY; HUMANS; IMMUNITY; IMMUNOCOMPROMISED HOST; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 84910012899     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2618     Document Type: Article

References (25)

1. Brun-Buisson C, Meshaka P, Pinton P, Vallet B; EPISEPSIS Study Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004;30(4):580-588.
2. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B; CUB-Réa Network. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med. 2003;168(2):165-172.
3. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28(2):108-121.
4. Vincent JL, Sakr Y, Sprung CL, et al; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344-353.
5. Vincent JL, Rello J, Marshall J, et al; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323-2329.
6. Adrie C, Alberti C, Chaix-Couturier C, et al. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care. 2005;20(1):46-58.
7. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17-60.
8. Linden PK. Approach to the immuno-compromised host with infection in the intensive care unit. Infect Dis Clin North Am. 2009;23(3):535-556.
9. Brun-Buisson C, Doyon F, Carlet J, et al; French ICU Group for Severe Sepsis. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA. 1995;274(12):968-974.
10. Japiassú AM, Amâncio RT, Mesquita EC, et al. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care. 2010;14(4):R152.
11. Soares M, Caruso P, Silva E, et al; Brazilian Research in Intensive Care Network (BRICNet). Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med. 2010;38(1):9-15.
12. Kroschinsky F, Weise M, Illmer T, et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med. 2002;28(9):1294-1300.
13. Pittet D, Thiévent B, Wenzel RP, Li N, Gurman G, Suter PM. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med. 1993;19(5):265-272.
14. Naccache JM. Pneumonia in the immuno-compromised patient [in French]. Rev Prat. 2011;61(8):1095-1101.
15. Alberti C, Brun-Buisson C, Goodman SV, et al; European Sepsis Group. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med. 2003;168(1):77-84.
16. Laupland KB, Zahar JR, Adrie C, et al. Severe hypothermia increases the risk for intensive care unit-acquired infection. Clin Infect Dis. 2012;54(8):1064-1070.
17. Knaus W, Draper E, Wagner D. APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Introduction. Crit Care Med. 1989;17(12 pt 2):S176-S180.
18. Resche-Rigon M, Azoulay E, Chevret S. Evaluating mortality in intensive care units: contribution of competing risks analyses. Crit Care. 2006;10(1):R5.
19. Angus DC, Barnato AE, Linde-Zwirble WT, et al; Robert Wood Johnson Foundation ICU End-Of-Life Peer Group. Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med. 2004;32(3):638-643.
20. Azoulay E, Mokart D, Pène F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium - a groupe de recherche respiratoire en réanimation oncohématologique study. J Clin Oncol. 2013;31(22):2810-2818.
21. Zahar JR, Timsit JF, Garrouste-Orgeas M, et al. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med. 2011;39(8):1886-1895.
22. Moreno RP, Metnitz PG, Almeida E, et al; SAPS 3 Investigators. SAPS 3 - From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31(10):1345-1355.
23. Hampshire PA, Welch CA, McCrossan LA, Francis K, Harrison DA. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care. 2009;13(4):R137.
24. Darmon M, Azoulay E, Alberti C, et al. Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med. 2002;28(12):1775-1780.
25. Vandijck DM, Benoit DD, Depuydt PO, et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med. 2008;34(5):847-855.